EANS-Adhoc: LifeWatch AG to report on Fourth Quarter 2011 and Full Fiscal Year 2011 Results on February 29, 2012 (with document)

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Analysts' Comments/LifeWatch AG

22.02.2012

- Press release and Letter to Shareholders at 7:00 a.m. CET (01:00
EST); - Analyst and media conference held in Zurich at 10:00 a.m.
CET; - International Live Conference Call/Audio web cast at 10:00
a.m. CET;

Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss
Exchange:LIFE) will report on its results for the fourth quarter 2011
and full fiscal year 2011 on Wednesday, February 29, 2012 in Zurich.

You will find a PDF-version of this invitation and a registration
form at the end of this message.

Press release and Letter to Shareholders at 7:00 a.m. CET (1:00 a.m.
EST):

LifeWatch will publish internationally the results for the fourth
quarter 2011 and full fiscal year 2011 in a press release and letter
to shareholders at 7:00 a.m. CET.

Analyst and media conference at 10:00 a.m. CET:

LifeWatch will report on the fourth quarter 2011 and full fiscal year
2011 results at an English-speaking analyst and media conference that
will take place in Zurich on:

Wednesday, February 29, 2012; at 10:00 a.m. CET at the Zunfthaus zur
Saffran, Limmatquai 54, 8001 Zurich/Switzerland.

Please confirm your participation at the analyst and media conference
by returning the registration form by Monday, February 27, 2012.

International Live Conference Call / Audio web cast at 10:00 a.m.
CET:

At 10:00 a.m. CET, LifeWatch will also discuss the results in a live
conference call and audio web cast which will be accompanied by
presentation visuals. The conference call is also accessible as an
audio web cast in the Investor Relations section of the LifeWatch
Website www.irlifewatch.com where an archived version will remain
available for download.

The local dial-in numbers for the conference call are as follows:

+ 41 (0)91 610 56 00 (Europe);
+ 44 (0)203 059 58 62 (UK);
+ 1 (1)866 291 41 66 (USA - Toll-free);

All participants are requested to dial in at least ten minutes prior
to the call. No PIN is required to access the call.

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
technology and solution company, specializing in advanced telehealth
systems and wireless remote patient monitoring services. LifeWatch
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services Inc., a leading US-based cardiac
monitoring service provider, and manufacturer of telecardiology
products. LifeWatch is also introducing a new program for Home Sleep
Testing of Obstructive Sleep Apnea (OSA) patients under the brand
name NiteWatch. For additional information, please visit
www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward- looking statements.
The words "believe," "may," "will," "estimate," "continue,"
"anticipate," "intend," "expect" and similar expressions are intended
to identify forward-looking statements. LifeWatch AG has based these
forward- looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward- looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/FXCyZ1yC
http://resources.euroadhoc.com/us/zkFOkW65

Further inquiry note:
Sensus Investor and Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

end of announcement euro adhoc
--------------------------------------------------------------------------------

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/FXCyZ1yC
http://resources.euroadhoc.com/us/zkFOkW65

issuer: LifeWatch AG
Rundbuckstrasse 6
CH-8212 Neuhausen am Rheinfall
phone: +41 52 632 00 50
FAX: +41 52 632 00 51
mail: users@lifewatch.com
WWW: www.lifewatch.com
sector: Healthcare Providers
ISIN: CH0012815459
indexes: SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
SIX Swiss Exchange
language: English